6-Mar-2026
No headlines found.
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
Business Wire (Thu, 12-Feb 4:06 PM ET)
Nu Skin Enterprises Announces Quarterly Dividend
Business Wire (Thu, 12-Feb 4:05 PM ET)
Business Wire (Fri, 6-Feb 1:56 PM ET)
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
Business Wire (Wed, 14-Jan 4:05 PM ET)
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference
Business Wire (Fri, 9-Jan 7:00 AM ET)
Nu Skin Releases 2024 Social Impact and Sustainability Report
Business Wire (Tue, 30-Dec 6:01 PM ET)
Nu Skin Unveils Prysm iO : An Evolution in Intelligent Nutritional Wellness
Business Wire (Thu, 18-Dec 10:01 AM ET)
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.
Nu Skin Enterprises trades on the NYSE stock market under the symbol NUS.
As of March 6, 2026, NUS stock price declined to $7.63 with 412,839 million shares trading.
NUS has a beta of 1.40, meaning it tends to be more sensitive to market movements. NUS has a correlation of 0.15 to the broad based SPY ETF.
NUS has a market cap of $367.21 million. This is considered a Small Cap stock.
Last quarter Nu Skin Enterprises reported $370 million in Revenue and $.29 earnings per share. This fell short of revenue expectation by $-12 million and missed earnings estimates by -$.01.
In the last 3 years, NUS traded as high as $41.50 and as low as $5.32.
The top ETF exchange traded funds that NUS belongs to (by Net Assets): VTI, FNDA, AVUV, IWM, VDC.
NUS has underperformed the market in the last year with a price return of -2.1% while the SPY ETF gained +18.7%. NUS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.9% and -11.7%, respectively, while the SPY returned -1.7% and -2.5%, respectively.
NUS support price is $7.40 and resistance is $7.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUS shares will trade within this expected range on the day.